Table 2 Results of the control group with the 3 study groups
From: The effects of levosimendan and dobutamine in experimental bupivacaine-induced cardiotoxicity
Study groups | Control | Levosimendan | Dobutamine | Dobutamine+Levosimendan |
|---|---|---|---|---|
Initial QRS > 20% (s) | 162 (101-342) | 173 (103-403) | 153 (105-410) | 159 (90-432) |
Initial arrhythmia (s) | 203 (129-549) | 455 (153-850) | 448 (249-1367) | 310 (97-567) |
Heart rate < 50% (s) | 345 (214-583) | 903* (301-1848) | 984 *(672-2814) | 1705 †* (1039-3009) |
Heart rate < %75 (s) | 538 (353-961) | 1198* (358-7014) | 1542 * (895-4092 | 3152 †* (1747-6519 |
Mean arterial pressure < %50 (s) | 399 (245-665) | 1005* (243-1592) | 685* (514-1992) | 1544 †* (874-3003) |
Mean arterial pressure < %75 (s) | 504 (381-814) | 1204* (298-6028) | 1009* (698-4013) | 2982 †* (1542-6897) |
Cardiac arrest time (s) | 703 (403-1049) | 1385* (412-6552) | 1789 * (944-4742) | 3357 †* (1825-7200) |
Total Bupivacaine dose (μg) | 8.48 (5.03-13.11) | 17.62 * (5.15-90.0) | 22.36 * (11.80-59.20) | 41.90 †* (22.80-90.0) |